HIV
A case study from the Tianjin Centers for Disease Control and Prevention in China has revealed that improper use of pre-exposure prophylaxis (PrEP) can lead to breakthrough infections and diagnostic challenges. Despite the high efficacy of PrEP in preventing HIV infection among men who have sex with men (MSM), the
AIDS vaccines
A recent study on the Immune System Diseases and Conditions - HIV/AIDS has shed light on how sex, race, and geographic location may influence the effectiveness of HIV vaccines. The research, conducted by LMU University Hospital, involved a randomized, double-blinded, placebo-controlled phase 2 trial that enrolled 480 Black and
HIV
Research published in the journal Communications Medicine has shed new light on the persistence of HIV-1 in the body, with findings suggesting that long-term persistence depends in part on tissue-specific integration site features. According to the study, HIV-1 persists in the body even when treatment suppresses viral replication, and this
Disclosure of information
Research published in the AIDS Research and Therapy journal has found that non-disclosure of HIV status may protect individuals from stigma, discrimination, and violence, but also limits access to social support and treatment adherence. A study conducted in Cameroon examined factors associated with non-disclosure among recently diagnosed individuals entering HIV
HIV
Researchers at Paris-Saclay University have conducted a study to understand sexual health among young adults living with perinatally-acquired HIV (PHIV) in France. The study, part of the ANRS-COVERTE-CO19 cohort, aimed to compare sexual health indicators among PHIV adults aged 18 to 25 with their peers in the general population. The
COVID-19
COVID-19 forced community-based peer support programs in Australia to rapidly adapt to digital service delivery, with challenges and opportunities arising from this shift. Research by Australian investigators highlighted the impact of moving to digital service delivery on how peer support programs were delivered and the effects on peer support workers.
Diseases
Researchers from the Guangxi Center for Disease Control and Prevention have made a significant discovery in understanding the profiles of HIV-related stigma and the predictors of profile transition among people living with HIV (PLWH) in China. Using a longitudinal socio-epidemiological research design, the study analyzed data from 1,198 PLWH
Cardiovascular diseases
People with HIV are at high risk of recurrent cardiovascular events, particularly those with atherosclerotic cardiovascular disease (ASCVD). Researchers from the University Medical Center Utrecht studied a large cohort of individuals with HIV and controls without HIV to estimate the 10-year recurrence risk and the potential benefits of guideline-recommended interventions.
Collateralized debt obligations
A recent study from Aga Khan University Hospital in Pakistan sheds light on the effects of emotional intelligence and employment on the psychological well-being of key populations working in HIV community-based organizations. The research focused on men who have sex with men, trans women, and female sex workers, exploring how
HIV
Research has shed light on the complexities surrounding the HIV care continuum, highlighting multiple barriers that hinder retention in care, including structural, systemic, and individual factors. A recent study conducted at the NOVA Southeastern University examined individuals living with HIV (PLH) who had detectable HIV-1 viral loads, with the goal
Highly active antiretroviral therapy
New research on immune system diseases and conditions reveals that antiretroviral treatments have varying efficacy and safety profiles in patients with late diagnosis of HIV/AIDS. The study, conducted in Berlin, Germany, compared the outcomes of patients starting first-line antiretroviral treatment (ART) with either dolutegravir/lamivudine (DTG/3TC) or bictegravir/
HIV
Researchers from Azienda Ospedale University Policlinico in Modena, Italy, have found that switching to a two-drug regimen (2DR) may reduce the clinical risk in virologically suppressed patients with HIV (PWH) compared to remaining on a three-drug regimen (3DR). The study, which included a large cohort of PWH in Italy, found
